BioLineRx Ltd. (BLRX)
3.00
+0.19
(+6.76%)
USD |
NASDAQ |
Aug 24, 16:00
2.80
-0.20
(-6.67%)
After-Hours: 20:00
BioLineRx Market Cap : 13.05M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 13.05M |
| August 21, 2026 | 12.23M |
| August 20, 2026 | 12.01M |
| August 19, 2026 | 12.75M |
| August 18, 2026 | 12.40M |
| August 17, 2026 | 11.49M |
| August 14, 2026 | 12.01M |
| August 13, 2026 | 11.83M |
| August 12, 2026 | 11.71M |
| August 11, 2026 | 12.08M |
| August 10, 2026 | 11.80M |
| August 07, 2026 | 11.79M |
| August 06, 2026 | 12.14M |
| August 05, 2026 | 11.82M |
| August 04, 2026 | 12.01M |
| August 03, 2026 | 11.56M |
| July 31, 2026 | 12.27M |
| July 30, 2026 | 11.75M |
| July 29, 2026 | 11.97M |
| July 28, 2026 | 12.23M |
| July 27, 2026 | 12.26M |
| July 24, 2026 | 12.27M |
| July 23, 2026 | 12.44M |
| July 22, 2026 | 12.39M |
| July 21, 2026 | 12.71M |
| Date | Value |
|---|---|
| July 20, 2026 | 12.31M |
| July 17, 2026 | 12.62M |
| July 16, 2026 | 12.97M |
| July 15, 2026 | 12.66M |
| July 14, 2026 | 13.27M |
| July 13, 2026 | 13.49M |
| July 10, 2026 | 13.45M |
| July 09, 2026 | 13.18M |
| July 08, 2026 | 13.10M |
| July 07, 2026 | 13.74M |
| July 06, 2026 | 13.74M |
| July 02, 2026 | 14.29M |
| July 01, 2026 | 13.79M |
| June 30, 2026 | 13.58M |
| June 29, 2026 | 13.49M |
| June 26, 2026 | 13.77M |
| June 25, 2026 | 13.55M |
| June 24, 2026 | 14.66M |
| June 23, 2026 | 14.19M |
| June 22, 2026 | 14.10M |
| June 18, 2026 | 13.75M |
| June 17, 2026 | 13.14M |
| June 16, 2026 | 13.27M |
| June 15, 2026 | 14.12M |
| June 12, 2026 | 14.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| XTL Biopharmaceuticals Ltd. | 6.210M |
| Kamada Ltd. | 486.36M |
| Can-Fite BioPharma Ltd. | 4.390M |
| Galmed Pharmaceuticals Ltd. | 3.341M |
| Revium Recovery, Inc. | 86.84M |
Market Cap Related Metrics
| PS Ratio | 9.082 |
| PEG Ratio | -0.0014 |
| Price to Book Value | 0.7829 |
| Price | 3.00 |
| Earnings Yield | -71.36% |
| PEGY Ratio | -0.0014 |